Disc Medicine (IRON) Other Working Capital Changes (2020 - 2026)
Disc Medicine (IRON) reported Other Working Capital Changes of -$168000.0 for Q1 2026, down 138.62% year-over-year from $435000.0 in Q1 2025, and down 112.16% on a QoQ basis from $1.4 million in Q4 2025.
Disc Medicine (IRON) has 7 years of Other Working Capital Changes data on file, last reported at -$168000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 138.62% year-over-year to -$168000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 million (up 574.56% YoY) and the FY2025 annual result came in at $8177.0, down 35.88% from the prior year.
- Other Working Capital Changes eased to -$168000.0 in Q1 2026 per IRON's latest filing, from $1.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $7.5 million in Q2 2025 and bottomed at -$3.2 million in Q1 2022.
- The 5-year median for Other Working Capital Changes is $12308.0 (2024), against an average of $469143.1.
- The widest annual swing landed in 2024, when Other Working Capital Changes plunged 3588.24%; it then jumped 62450.2% in 2025.
- Tracing IRON's Other Working Capital Changes over 5 years: stood at -$4000.0 in 2022, then jumped by 950.0% to $34000.0 in 2023, then sank by 3588.24% to -$1.2 million in 2024, then soared by 216.53% to $1.4 million in 2025, then slumped by 112.16% to -$168000.0 in 2026.
- Per Business Quant, the three latest IRON Other Working Capital Changes figures stand at -$168000.0 (Q1 2026), $1.4 million (Q4 2025), and -$371000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -168,000.00 |
| Mar 31, 2026 | -168,000.00 |
| Dec 31, 2025 | 1.38 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | -371,000.00 |
| Sep 30, 2025 | -371,000.00 |
| Jun 30, 2025 | 7.48 Mn |
| Jun 30, 2025 | 7.48 Mn |
| Mar 31, 2025 | 435,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Dec 31, 2024 | -1.19 Mn |
| Dec 31, 2024 | -1.19 Mn |
| Sep 30, 2024 | 12,664.00 |
| Sep 30, 2024 | 12,664.00 |
| Jun 30, 2024 | 11,952.00 |
| Jun 30, 2024 | 11,952.00 |
| Mar 31, 2024 | 1,244.00 |
| Mar 31, 2024 | 1,244.00 |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 70,430.00 |
| Sep 30, 2023 | 70,430.00 |
| Jun 30, 2023 | -1.04 Mn |
| Jun 30, 2023 | -1.04 Mn |
| Mar 31, 2023 | 908,000.00 |
| Mar 31, 2023 | 908,000.00 |
| Sep 30, 2022 | -4,000.00 |
| Sep 30, 2022 | -4,000.00 |
| Jun 30, 2022 | 3.14 Mn |
| Jun 30, 2022 | 3.14 Mn |
| Mar 31, 2022 | -3.20 Mn |
| Mar 31, 2022 | -3.20 Mn |
| Dec 31, 2021 | -373,000.00 |
| Dec 31, 2021 | -373,000.00 |
| Sep 30, 2021 | -327,000.00 |
| Sep 30, 2021 | -327,000.00 |
| Jun 30, 2021 | 334,000.00 |
| Jun 30, 2021 | 334,000.00 |
| Mar 31, 2021 | 225,000.00 |
| Mar 31, 2021 | 225,000.00 |
| Dec 31, 2020 | 125,948.00 |
| Dec 31, 2020 | 125,948.00 |
| Sep 30, 2020 | 169,570.00 |
| Sep 30, 2020 | 169,570.00 |
| Jun 30, 2020 | -499,000.00 |
| Jun 30, 2020 | -499,000.00 |
| Mar 31, 2020 | -117,000.00 |
| Mar 31, 2020 | -117,000.00 |